a pharmacological composition comprises a reverse transcriptase inhibitor in a quantity sufficient to reduce a viral serum titer of a virus in an amount of at least 20 % over a period of at least 6 hours , wherein preferred reverse transcriptase inhibitor comprise a plant extract .